People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precision Biosciences Inc | — | Biotechnology | Series C | $153.3M | $1.6B | 2015 |
| Metacrine, Inc. | — | Pharmaceuticals | Series C | $124.8M | $2.3B | 2015 |
| Sientra, Inc. | — | Other Health Care | Series C | $65.0M | $1.5B | 2012 |
| Solstice Biologics LLC | — | Pharmaceuticals | Series A | $22.0M | $123.9M | 2012 |
| Cerimon Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.7M | $8.9M | 2009 |
Robert Adelman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Adelman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JEFF SMITH | 1 | 17 |
| Kristina Burow | 1 | 16 |
| Amir Nashat | 1 | 14 |
| Corey Goodman | 1 | 13 |
| Rishi Gupta | 1 | 12 |
| Ben Auspitz | 1 | 9 |
| Ansbert Gadicke | 1 | 7 |
| Carol Gallagher | 1 | 6 |
| MATTHEW KANE | 1 | 4 |
| Shalini Sharp | 1 | 4 |
| Neil McDonnell | 1 | 4 |
| Frank Muhlenbeck | 1 | 4 |
| James H. Welch | 1 | 3 |
| Tony Yao | 1 | 3 |
| Nick Simon | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| John Borgeson | 1 | 3 |
| Louis Tartaglia | 1 | 3 |
| Joel Smith | 1 | 3 |
| Trisha Millican | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.